Accrual-Monitoring Practices for Various Disease Trials among AACI Member Cancer Centers

Accrual-Monitoring Practices for Various Disease Trials among AACI Member Cancer Centers

Progress in the management of rare diseases, including rare cancers, is dependent upon clinical trials; however, as many as 32% of rare-disease trials go uncompleted or unpublished due to insufficient accrual. Monitoring practices may differ between institutions. We sought to survey the regulatory s...

Full description

Bibliographic Details
Main Authors: Zachary T. Elliott, Zachary Goldberg, Ramez Philips, Jennifer M. Johnson, Margaret T. Kasner, William K. Kelly, Sarah Osipowicz, Rachael Dampman, Joseph M. Curry
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Clinics and Practice
Subjects:
rare diseases
clinical trials
accrual and monitoring
Online Access:https://www.mdpi.com/2039-7283/12/5/72

Internet

https://www.mdpi.com/2039-7283/12/5/72

Similar Items